scispace - formally typeset
J

Jytte Halkjaer

Researcher at German Cancer Research Center

Publications -  13
Citations -  634

Jytte Halkjaer is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Cancer. The author has an hindex of 7, co-authored 9 publications receiving 576 citations.

Papers
More filters
Journal ArticleDOI

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers-results from BPC3

TL;DR: While these SNPs represent new independent risk factors for prostate cancer, there is little evidence for effect modification by other SNPs or by the environmental factors examined, and no evidence of pair-wise SNP-SNP interactions.
Journal ArticleDOI

Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study

TL;DR: Using data on cancer incidence for 2008 and the AF(p) estimates, about 270,000 new cancer diagnoses per year can be considered attributable to cigarette smoking in the eight European countries with available data for both men and women.
Journal ArticleDOI

Physical activity and gain in abdominal adiposity and body weight: prospective cohort study in 288,498 men and women

TL;DR: It is suggested that a higher level of PA reduces abdominal adiposity independent of baseline and changes in body weight and is thus a useful strategy for preventing chronic diseases and premature deaths.
Journal ArticleDOI

A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)

TL;DR: Height and BMI are associated with IGF-I and its binding proteins, which may be mechanisms through which body size contributes to increased risk of several cancers.
Journal ArticleDOI

The association of circulating adiponectin levels with pancreatic cancer risk : A study within the prospective EPIC cohort

Verena A. Grote, +54 more
TL;DR: Overall, adiponectin showed no association with pancreas cancer risk; however, among never smokers, higher circulating levels of adiponECTin were associated with a reduction in pancreatic cancer risk, whereas among current smokers there was no significant association.